BACKGROUND: Methylenetetrahydrofolate (MTHFR) enzyme plays an important role in folate metabolism which is involved in DNA methylation, repair, and synthesis. OBJECTIVE: We investigated if the MTHFR C677T polymorphism modulates the risk of developing breast cancer in Moroccan women. METHODS: Genotyping was performed by PCR-RFLP method on a sample of 96 patients with breast cancer and 117 controls. RESULTS: A positive correlation was found between the MTHFR C677T polymorphism and progesterone receptors expression (p= 0.04). According to menopausal status, the heterozygous CT (OR = 2.29 and P = 0.03) was statistically significant in pre-menopausal women. There was a significant association between C677T polymorphism and breast cancer risk in both additive (OR = 2.2, 95% CI = 1.24-3.86, p = 0.007) and dominant (OR = 2.10, CI 95% = 1.21-3.64, p = 0.008) models. In addition, the T allele were associated with a high breast cancer risk (OR = 1.59, 95% CI = 1.04-2.44, p = 0.03). CONCLUSION: In the light of our preliminary study, 677T allele and 677CT MTHFR genotype may represent a genetic determinant increasing breast cancer risk in Moroccan women. A larger study including a larger sample size and more information is needed to confirm our conclusions.
BACKGROUND: Methylenetetrahydrofolate (MTHFR) enzyme plays an important role in folate metabolism which is involved in DNA methylation, repair, and synthesis. OBJECTIVE: We investigated if the MTHFRC677T polymorphism modulates the risk of developing breast cancer in Moroccan women. METHODS: Genotyping was performed by PCR-RFLP method on a sample of 96 patients with breast cancer and 117 controls. RESULTS: A positive correlation was found between the MTHFRC677T polymorphism and progesterone receptors expression (p= 0.04). According to menopausal status, the heterozygous CT (OR = 2.29 and P = 0.03) was statistically significant in pre-menopausal women. There was a significant association between C677T polymorphism and breast cancer risk in both additive (OR = 2.2, 95% CI = 1.24-3.86, p = 0.007) and dominant (OR = 2.10, CI 95% = 1.21-3.64, p = 0.008) models. In addition, the T allele were associated with a high breast cancer risk (OR = 1.59, 95% CI = 1.04-2.44, p = 0.03). CONCLUSION: In the light of our preliminary study, 677T allele and 677CT MTHFR genotype may represent a genetic determinant increasing breast cancer risk in Moroccan women. A larger study including a larger sample size and more information is needed to confirm our conclusions.
Entities:
Keywords:
MTHFR polymorphism; Morocco; breast neoplasm
Authors: B C Blount; M M Mack; C M Wehr; J T MacGregor; R A Hiatt; G Wang; S N Wickramasinghe; R B Everson; B N Ames Journal: Proc Natl Acad Sci U S A Date: 1997-04-01 Impact factor: 11.205
Authors: Debora Macis; Patrick Maisonneuve; Harriet Johansson; Bernardo Bonanni; Edoardo Botteri; Simona Iodice; Barbara Santillo; Silvana Penco; Giacomo Gucciardo; Giuseppe D'Aiuto; Marco Rosselli Del Turco; Marinella Amadori; Alberto Costa; Andrea Decensi Journal: Breast Cancer Res Treat Date: 2007-01-27 Impact factor: 4.872
Authors: P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel Journal: Nat Genet Date: 1995-05 Impact factor: 38.330
Authors: Uwe Langsenlehner; Peter Krippl; Wilfried Renner; Babak Yazdani-Biuki; Gerald Wolf; Thomas C Wascher; Bernhard Paulweber; Werner Weitzer; Hellmut Samonigg Journal: Breast Cancer Res Treat Date: 2003-09 Impact factor: 4.872